Haisheng Wang

USPTO Granted Patents = 28 (Patent Applications = 12)

CIPO Patents = 5 (Patent Applications = 2)

EPO Patents = 22 (Patent Applications = 20)

Average Co-Inventor Count = 4.5

ph-index = 14

Forward Citations = 1,022(Granted Patents)

Location History:

Wilmington, DE (US) (1999 - 2005)
Hockessin, DE (US) (2004 - 2024)

Company Filing History:

Incyte Holdings Corporation

patents

2 out of 3,685

Bristol-myers Squibb Compnay

Dupont Pharmaceuticals Company

patents

6. 1 out of 10

Bristol-myers Squibb Pharma Corporation

patents

7. 1 out of 234

Bristol-myers Squibb Pharma Company

patents

where one patent can have more than one assignee

Years Active: 1999-2025

Loading Chart...

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12187725 - Tricyclic urea compounds as JAK2 V617F inhibitors (2025-01-07),

2. 11952367 - Pyridine and pyridimine compounds as PI3K-gamma inhibitors (2024-04-09),

3. 11780840 - Tricyclic urea compounds as JAK2 V617F inhibitors (2023-10-10),

4. 11352340 - Pyridine and pyridimine compounds as PI3K-gamma inhibitors (2022-06-07),

5. 11091484 - Tricyclic heterocycles as BET protein inhibitors (2021-08-17),

6. 10975085 - Process for preparing a composition comprising an enantiomeric excess of greater than or equal to 90% of the (R)-enantiomer of a compound of formula III (2021-04-13),

7. 10442803 - Tricyclic heterocycles as bet protein inhibitors (2019-10-15),

8. 10364248 - Processes for preparing 4-chloro-7H-pyrrolo[2,3-d]pyrimidine (2019-07-30),

9. 9908888 - Processes for preparing pyrazolyl-substituted pyrrolo[2,3-d]pyrimidines (2018-03-06),

10. 9879010 - Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b] pyrimidin-5-yl-amines as Janus kinase inhibitors (2018-01-30),

11. 9777003 - Tricyclic heterocycles as bet protein inhibitors (2017-10-03),

12. 9580419 - Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as Janus kinase inhibitors (2017-02-28),

13. 9334274 - N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors (2016-05-10),

14. 9309246 - Tricyclic heterocycles as BET protein inhibitors (2016-04-12),

15. 9249145 - Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors (2016-02-02),

Title: Haisheng Wang: Pioneering Inventor from Hockessin

Introduction: Haisheng Wang is a distinguished inventor hailing from Hockessin, Delaware. His innovative spirit and dedication to technological advancements have made him a prominent figure in the world of patents and inventions.

Latest Patents: Haisheng Wang holds several groundbreaking patents in the fields of renewable energy, sustainable technologies, and advanced materials. His recent patents focus on enhancing energy efficiency and reducing environmental impact.

Career Highlights: With a career spanning over two decades, Haisheng Wang has worked with leading research institutions and companies to develop cutting-edge solutions. His contributions have significantly impacted industries such as clean energy, biotechnology, and electronics.

Collaborations: Throughout his career, Haisheng Wang has collaborated with top scientists, engineers, and inventors to push the boundaries of innovation. His collaborative efforts have resulted in transformative technologies that address global challenges.

Conclusion: Haisheng Wang's relentless pursuit of innovation and his passion for creating a sustainable future have solidified his reputation as a visionary inventor. His work continues to inspire the next generation of inventors and researchers worldwide.

This text is generated by artificial intelligence and may not be accurate.